Trial Profile
Evaluation of changes in mammographic breast density associated with bazedoxifene, raloxifene, and placebo in postmenopausal women: an ancillary study of protocol 3068A1-301-WW
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Sep 2010
Price :
$35
*
At a glance
- Drugs Bazedoxifene (Primary) ; Raloxifene (Primary)
- Indications Menopause
- Focus Pharmacodynamics
- Sponsors Pfizer; Wyeth
- 17 Aug 2010 Actual end date changed from Sep 2007 to Apr 2010 as reported by ClinicalTrials.gov.
- 04 Dec 2007 Status change from in progress to completed.
- 18 Jan 2007 New trial record.